Previous Article | Next Article 
Molecular and Cellular Biology, December 1998, p. 7432-7443, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Leukemic Protein Core Binding Factor
(CBF
)-Smooth-Muscle Myosin Heavy Chain Sequesters CBF
2 into
Cytoskeletal Filaments and Aggregates
Neeraj
Adya,1
Terryl
Stacy,2
Nancy A.
Speck,2 and
Pu Paul
Liu1,*
Oncogenesis and Development Section, Genetics
and Molecular Biology Branch, National Human Genome Research
Institute, National Institutes of Health, Bethesda, Maryland
20892,1 and
Department of
Biochemistry, Dartmouth Medical School, Hanover, New Hampshire
037552
Received 31 March 1998/Returned for modification 19 May
1998/Accepted 10 September 1998
The fusion gene CBFB-MYH11 is generated by the
chromosome 16 inversion associated with acute myeloid leukemias. This
gene encodes a chimeric protein involving the core binding factor
(CBF
) and the smooth-muscle myosin heavy chain (SMMHC). Mouse model studies suggest that this chimeric protein CBF
-SMMHC
dominantly suppresses the function of CBF, a heterodimeric
transcription factor composed of DNA binding subunits (CBF
1 to 3)
and a non-DNA binding subunit (CBF
). This dominant suppression
results in the blockage of hematopoiesis in mice and
presumably contributes to leukemogenesis. We used
transient-transfection assays, in combination with immunofluorescence
and green fluorescent protein-tagged proteins, to monitor
subcellular localization of CBF
-SMMHC, CBF
, and CBF
2 (also
known as AML1 or PEBP2
B). When expressed individually, CBF
2
was located in the nuclei of transfected cells, whereas CBF
was
distributed throughout the cell. On the other hand, CBF
-SMMHC formed
filament-like structures that colocalized with actin filaments. Upon
cotransfection, CBF
2 was able to drive localization of CBF
into
the nucleus in a dose-dependent manner. In contrast, CBF
2 colocalized with CBF
-SMMHC along the filaments instead of
localizing to the nucleus. Deletion of the CBF
-interacting domain
within CBF
-SMMHC abolished this CBF
2 sequestration, whereas
truncation of the C-terminal-end SMMHC domain led to nuclear
localization of CBF
-SMMHC when coexpressed with CBF
2.
CBF
2 sequestration by CBF
-SMMHC was further confirmed in
vivo in a knock-in mouse model. These observations suggest that
CBF
-SMMHC plays a dominant negative role by sequestering CBF
2
into cytoskeletal filaments and aggregates, thereby disrupting
CBF
2-mediated regulation of gene expression.
*
Corresponding author. Mailing address: NHGRI, National
Institutes of Health, 49 Convent Dr., Room 3C28, Bethesda, MD 20892. Phone: (301) 402-2529. Fax: (301) 402-4929. E-mail:
pliu{at}nhgri.nih.gov.
Molecular and Cellular Biology, December 1998, p. 7432-7443, Vol. 18, No. 12
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wee, H.-J., Voon, D. C.-C., Bae, S.-C., Ito, Y.
(2008). PEBP2-{beta}/CBF-{beta}-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis. Blood
112: 3777-3787
[Abstract]
[Full Text]
-
Kim, H.-G., Kojima, K., Swindle, C. S., Cotta, C. V., Huo, Y., Reddy, V., Klug, C. A.
(2008). FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia. Blood
111: 1567-1574
[Abstract]
[Full Text]
-
Kagoshima, H., Nimmo, R., Saad, N., Tanaka, J., Miwa, Y., Mitani, S., Kohara, Y., Woollard, A.
(2007). The C. elegans CBF{beta} homologue BRO-1 interacts with the Runx factor, RNT-1, to promote stem cell proliferation and self-renewal. Development
134: 3905-3915
[Abstract]
[Full Text]
-
Zhao, L., Cannons, J. L., Anderson, S., Kirby, M., Xu, L., Castilla, L. H., Schwartzberg, P. L., Bosselut, R., Liu, P. P.
(2007). CBFB-MYH11 hinders early T-cell development and induces massive cell death in the thymus. Blood
109: 3432-3440
[Abstract]
[Full Text]
-
Markus, J., Garin, M. T., Bies, J., Galili, N., Raza, A., Thirman, M. J., Le Beau, M. M., Rowley, J. D., Liu, P. P., Wolff, L.
(2007). Methylation-Independent Silencing of the Tumor Suppressor INK4b (p15) by CBF{beta}-SMMHC in Acute Myelogenous Leukemia with inv(16). Cancer Res.
67: 992-1000
[Abstract]
[Full Text]
-
Frohling, S., Scholl, C., Gilliland, D. G., Levine, R. L.
(2005). Genetics of Myeloid Malignancies: Pathogenetic and Clinical Implications. JCO
23: 6285-6295
[Abstract]
[Full Text]
-
Yang, G., Khalaf, W., van de Locht, L., Jansen, J. H., Gao, M., Thompson, M. A., van der Reijden, B. A., Gutmann, D. H., Delwel, R., Clapp, D. W., Hiebert, S. W.
(2005). Transcriptional Repression of the Neurofibromatosis-1 Tumor Suppressor by the t(8;21) Fusion Protein. Mol. Cell. Biol.
25: 5869-5879
[Abstract]
[Full Text]
-
Wildonger, J., Mann, R. S.
(2005). The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor. Development
132: 2263-2272
[Abstract]
[Full Text]
-
Howcroft, T. K., Weissman, J. D., Gegonne, A., Singer, D. S.
(2005). A T Lymphocyte-Specific Transcription Complex Containing RUNX1 Activates MHC Class I Expression. J. Immunol.
174: 2106-2115
[Abstract]
[Full Text]
-
Yoshida, N., Ogata, T., Tanabe, K., Li, S., Nakazato, M., Kohu, K., Takafuta, T., Shapiro, S., Ohta, Y., Satake, M., Watanabe, T.
(2005). Filamin A-Bound PEBP2{beta}/CBF{beta} Is Retained in the Cytoplasm and Prevented from Functioning as a Partner of the Runx1 Transcription Factor. Mol. Cell. Biol.
25: 1003-1012
[Abstract]
[Full Text]
-
So, C. W., Cleary, M. L.
(2004). Dimerization: a versatile switch for oncogenesis. Blood
104: 919-922
[Abstract]
[Full Text]
-
Huang, G., Shigesada, K., Wee, H.-J., Liu, P. P., Osato, M., Ito, Y.
(2004). Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera. Blood
103: 3200-3207
[Abstract]
[Full Text]
-
Zhang, L., Li, Z., Yan, J., Pradhan, P., Corpora, T., Cheney, M. D., Bravo, J., Warren, A. J., Bushweller, J. H., Speck, N. A.
(2003). Mutagenesis of the Runt Domain Defines Two Energetic Hot Spots for Heterodimerization with the Core Binding Factor {beta} Subunit. J. Biol. Chem.
278: 33097-33104
[Abstract]
[Full Text]
-
Durst, K. L., Lutterbach, B., Kummalue, T., Friedman, A. D., Hiebert, S. W.
(2003). The inv(16) Fusion Protein Associates with Corepressors via a Smooth Muscle Myosin Heavy-Chain Domain. Mol. Cell. Biol.
23: 607-619
[Abstract]
[Full Text]
-
Kummalue, T., Lou, J., Friedman, A. D.
(2002). Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBF{beta}-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein. Mol. Cell. Biol.
22: 8278-8291
[Abstract]
[Full Text]
-
Kundu, M., Chen, A., Anderson, S., Kirby, M., Xu, L., Castilla, L. H., Bodine, D., Liu, P. P.
(2002). Role of Cbfb in hematopoiesis and perturbations resulting from expression of the leukemogenic fusion gene Cbfb-MYH11. Blood
100: 2449-2456
[Abstract]
[Full Text]
-
Hussey, D. J., Dobrovic, A.
(2002). Recurrent coiled-coil motifs in NUP98 fusion partners provide a clue to leukemogenesis. Blood
99: 1097-1097
[Full Text]
-
Kaminker, J. S., Singh, R., Lebestky, T., Yan, H., Banerjee, U.
(2001). Redundant function of Runt Domain binding partners, Big brother and Brother, during Drosophila development. Development
128: 2639-2648
[Abstract]
[Full Text]
-
Miller, J. D., Stacy, T., Liu, P. P., Speck, N. A.
(2001). Core-binding factor {beta} (CBF{beta}), but not CBF{beta}-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBF{beta}-deficient embryonic stem cells. Blood
97: 2248-2256
[Abstract]
[Full Text]
-
Blake, T., Adya, N., Kim, C.-H., Oates, A. C., Zon, L., Chitnis, A., Weinstein, B. M., Liu, P. P.
(2000). Zebrafish homolog of the leukemia gene CBFB: its expression during embryogenesis and its relationship to scl and gata-1 in hematopoiesis. Blood
96: 4178-4184
[Abstract]
[Full Text]
-
Gu, T.-L., Goetz, T. L., Graves, B. J., Speck, N. A.
(2000). Auto-Inhibition and Partner Proteins, Core-Binding Factor beta (CBFbeta ) and Ets-1, Modulate DNA Binding by CBFalpha 2 (AML1). Mol. Cell. Biol.
20: 91-103
[Abstract]
[Full Text]
-
Lutterbach, B., Hou, Y., Durst, K. L., Hiebert, S. W.
(1999). The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor. Proc. Natl. Acad. Sci. USA
96: 12822-12827
[Abstract]
[Full Text]
-
Osaka, M., Rowley, J. D., Zeleznik-Le, N. J.
(1999). MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc. Natl. Acad. Sci. USA
96: 6428-6433
[Abstract]
[Full Text]
-
Li, L., Gergen, J.
(1999). Differential interactions between Brother proteins and Runt domain proteins in the Drosophila embryo and eye. Development
126: 3313-3322
[Abstract]